Cronos Group Stock (NASDAQ:CRON)
Previous Close
$2.85
52W Range
$1.91 - $3.43
50D Avg
$2.70
200D Avg
$2.63
Market Cap
$1.04B
Avg Vol (3M)
$1.51M
Beta
1.25
Div Yield
-
CRON Company Profile
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
CRON Performance
Peer Comparison
| Ticker | Company |
|---|---|
| BBOT | BridgeBio Oncology Therapeutics Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
| EMBC | Embecta Corp. |
| RAPP | Rapport Therapeutics, Inc. Common Stock |
| NRIX | Nurix Therapeutics, Inc. |
| XNCR | Xencor, Inc. |
| IRMD | IRadimed Corporation |
| COLL | Collegium Pharmaceutical, Inc. |
| PHAT | Phathom Pharmaceuticals, Inc. |
| PCRX | Pacira BioSciences, Inc. |